Med Check
Med Check
Psychiatric News
Volume 45 Number 17 page 16-16

• AstraZeneca announced in August that it had reached agreements in principle on monetary terms with attorneys representing approximately 17,500 Seroquel product-liability claimants in the United States for approximately $198 million. The agreements in principle are subject to agreement on nonmonetary terms. The settlement stems from claims that the company marketed Seroquel, which is approved for treatment of psychosis, for off-label indications.


The study, funded by Shire, is posted at <www.behavioralandbrainfunctions.com/>.blacksquare

Interactive Graphics


Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles